Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 16;14(14):5054.
doi: 10.3390/jcm14145054.

Does Cannabis Smoke Cause Interstitial Lung Disease?

Affiliations

Does Cannabis Smoke Cause Interstitial Lung Disease?

Mario Bisconti et al. J Clin Med. .

Abstract

Background/Objectives: The correlation between drugs and interstitial lung disease (ILD) is reported, but the presence of the substances of abuse in the lung as a cause of disease has never been proved. In this observational study, our aim was to evaluate a possible correlation between ILD radiological findings and cannabinoids presence in broncho-alveolar lavage (BAL) or in resected lung tissue in patients with a history of cannabis smoke. Methods: Data of patients with ILD chest CT scan findings and history of drug use, submitted to BAL (Group 1), or to lung apex removal for pneumothorax (Group 2), were retrospectively collected. In both groups, drug presence was investigated. A subgroup of Group 1 was checked for the concomitant presence in blood. Fisher's test was used to study the association between the detection of the drug and ILD. Results: In Group 1, cannabinoids were present in 12/26 (46.2%) BAL samples. ILD emerged on chest CT in 75% of the cannabinoid-positive and in 20% of the cannabinoid-negative BAL samples (p = 0.0299). In the subgroup, the patients who tested positive for cannabinoids/cocaine on BAL were 55.6%; 0% were positive only on blood (p = 0.0294). In Group 2, cannabinoids were present in 10/15 (66.7%) specimens. ILD was evident, respectively, in 40% and in 0% of the patients with cannabinoid-positive and cannabinoid-negative surgical specimens (p = 0.2308). Conclusions: The prevalence of ILD in patients with cannabinoid-positive BAL and in those with cannabinoid-positive surgical specimens suggests that ILD could be caused by cannabis smoke. The non-concomitant presence of substances in BAL and in blood advocates the diagnostic usefulness of searching for the drug in the target organ.

Keywords: biomarker; broncho-alveolar lavage; bronchoscopy; cannabinoids; cannabis smoke; drugs; interstitial lung disease; lung tissue; pneumothorax.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Chest CT of one of the patients with cannabinoid-positive BAL showing bilateral ground-glass opacities (GGO), demarcated by areas of normal lung parenchyma, creating a “mosaic” lung pattern; in the context of the GGO, thickening of the lung interstitium with formation of microcysts can be seen.
Figure 2
Figure 2
Magnification of 250×, hematoxilin–eosin staining (HE): elongated needle-like inclusions crossing almost the entire body of a multinucleated cell. The evaluation under a polarized light microscope highlighted the birefringence of the needle-like inclusions and crystals with a morphology of organic fibers, such as cellulose, thus suggesting the diagnosis of pulmonary fibrosis and granulomatosis from cellulose-cut cocaine.

References

    1. Mégarbane B., Chevillard L. The large spectrum of pulmonary complications following illicit drug use: Features and mechanisms. Chem. Biol. Interact. 2013;206:444–451. doi: 10.1016/j.cbi.2013.10.011. - DOI - PubMed
    1. de Almeida R.R., Zanetti G., Souza A.S., Jr., de Souza L.S., Silva J.L., Escuissato D.L., Irion K.L., Mançano A.D., Nobre L.F., Hochhegger B., et al. Cocaine-induced pulmonary changes: HRCT findings. J. Bras. Pneumol. 2015;41:323–330. doi: 10.1590/S1806-37132015000000025. - DOI - PMC - PubMed
    1. Restrepo C.S., Carrillo J.A., Martínez S., Ojeda P., Rivera A.L., Hatta A. Pulmonary complications from cocaine and cocaine-based substances: Imaging manifestations. Radiographics. 2007;27:941–956. doi: 10.1148/rg.274065144. - DOI - PubMed
    1. Alzghoul B.N., Abualsuod A., Alqam B., Innabi A., Palagiri D.R., Gheith Z., Amer F.N., Meena N.K., Kenchaiah S. Cocaine use and pulmonary ipertension. Am. J. Cardiol. 2020;125:282–288. doi: 10.1016/j.amjcard.2019.10.008. - DOI - PMC - PubMed
    1. Oubeid M., Bickel J.T., Ingram F.A., Scott G.C. Pulmonary talc granulomatosis in a cocaine sniffer. Chest. 1990;98:237–239. doi: 10.1378/chest.98.1.237. - DOI - PubMed

LinkOut - more resources